Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma

Fig. 6

Schematic illustration of CRBP-1 inhibiting cancer stemness via regulating wnt/β-catenin signaling pathway in HCC. CRBP-1 induces the intracellular levels of RA, which activates RAR/RXR and transcriptionally promotes the expression of WIF1 via activating RAREs in its promoter region, thus downregulates the expression of β-catenin and its correlated genes, consequently suppress the cancer stemness properties leading to the inhibition of HCC tumorigenesis

Back to article page